• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    New onset hypertension after transplantation

    2022-07-29 05:41:40MahmoudNassarNsoNsoSofiaLakhdarRavaliKondaveetiChandanButtarHarangadBhangooMahmoudAwadNaveenSiddiqueSheikhKarimSolimanMostSirajumMuniraFarshidRadparvarVincentRizzoAhmedDaoud
    World Journal of Transplantation 2022年3期

    Mahmoud Nassar, Nso Nso, Sofia Lakhdar, Ravali Kondaveeti, Chandan Buttar, Harangad Bhangoo,Mahmoud Awad, Naveen Siddique Sheikh, Karim M Soliman, Most Sirajum Munira, Farshid Radparvar,Vincent Rizzo, Ahmed Daoud

    Mahmoud Nassar, Nso Nso, Sofia Lakhdar, Ravali Kondaveeti, Chandan Buttar, Harangad Bhangoo, Vincent Rizzo, Department of Medicine, Icahn School of Medicine at Mount Sinai (NYC Health and Hospitals: Queens), New York, NY 11432, United States

    Mahmoud Awad, Department of Medicine, The Memorial Souad Kafafi University Hospital, 6th of October - Giza 0000, Egypt

    Naveen Siddique Sheikh, Department of Physiology, CMH Lahore Medical College and Institute of Dentistry, Lahore - Punjab 0000, Pakistan

    Karim M Soliman, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, United States

    Most Sirajum Munira, Farshid Radparvar, Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai (NYC Health and Hospitals: Queens), New York, NY 11432, United States

    Ahmed Daoud, Department of Medicine, Kasr Alainy Medical School, Cairo University, Cairo 11211, Egypt

    Abstract It has been reported that up to 90% of organ transplant recipients have suboptimal blood pressure control. Uncontrolled hypertension is a well-known culprit of cardiovascular and overall morbidity and mortality. In addition, rigorous control of hypertension after organ transplantation is a crucial factor in prolonging graft survival. Nevertheless, hypertension after organ transplantation encompasses a broader range of causes than those identified in non-organ transplant patients. Hence, specific management awareness of those factors is mandated. An in-depth understanding of hypertension after organ transplantation remains a debatable issue that necessitates further clarification. This article provides a comprehensive review of the prevalence, risk factors, etiology, complications, prevention, and management of hypertension after organ transplantation.

    Key Words: New onset; Hypertension; Organ; Transplantation; Renal

    INTRODUCTION

    The systolic blood pressure of more than 130 mmHg or diastolic blood pressure of above 80 mmHg leads to the development of hypertension requiring medical managementviaantihypertensive medications[1]. The primary and secondary blood pressure elevations potentially increase the risk of various cardiovascular complications. Secondary hypertension develops under the impact of several morbidities and comorbidities. Organ transplantation based on heart, kidney, lung, bone marrow, and liver predisposes 70%-90% of the treated patients to hypertension that potentially impacts their overall survival[2]. The development of posttransplant hypertension also leads to graft-related complications. The systematic prevention and control of organ transplant-related hypertension are paramount to reducing the risk of morbidity/mortality. This review elaborates on the complications, etiology, risk factors, prevalence, incidence, and medical management of hypertension occurring after organ transplantation.

    KIDNEY TRANSPLANTATION

    Most of renal transplant recipients are already hypertensive before transplant. The prevalence of hypertension in end stage renal disease is around 70%-80%. Hypertension improves in some patients after renal transplantation with the improvement of the renal functions, many patients continue to have renal transplantation related hypertension after transplantation[3].

    The renal transplantation-related hypertension prevalence among 47%-82% of children and 50%-80% adults potentially deteriorate their prognostic outcomes. However, the variations in hypertension prevalence between the patient populations potentially deteriorate their medical management and treatment outcomes. More than 27.6% of patients experience hypertension within one year of their organ transplantation. The utilization of immunosuppressants, organ rejection, graft dysfunction, long surgery duration, and advanced donor age are the significant factors that increase the risk of organ transplantation-related hypertension[4]. Other predisposing factors include post-biopsy arteriovenous fistula, post-transplantation glomerulonephritis/renal artery stenosis, and family history of hypertension among organ donors[5].

    HEART TRANSPLANTATION

    Seventy percent of patients who receive heart transplants experience hypertension and its clinical complications[6]. The elderly hypertensive patients with heart transplant status often experience a marked reduction in estimated glomerular filtration rate and elevation in serum creatinine levels. The findings by United Network for Organ Sharing database indicate hypertension predisposition among heart transplant recipients with age sixty years or above compared to other age groups[7]. The clinical studies reveal a reduction in hypertension incidence among patients who undergo heterotrophic cardiac transplants[8]. The patients who receive an orthotopic heart transplant, however, experience a high risk for hypertension. The obese patients undergoing heart transplantation also remain highly predisposed to hypertensive heart disease. The dependence on steroids, calcineurin inhibitors, and other immunosuppressants further increase the risk of hypertension among heart transplant recipients. Medical literature correlates 70%-90% incidence of hypertension with the use of calcineurin inhibitors among heart transplant patients[9].

    LUNG TRANSPLANTATION

    A reportable number of patients develop new-onset/episodic hypertension after undergoing lung transplantation. Medical literature confirms the cumulative prevalence of new-onset hypertension among 45% (at one year), 56% (at two years), and 63% (at three years) of lung transplant recipients. These patients frequently develop comorbidities, including diabetes mellitus and hypercholesterolemia[10]. The lung transplant patients who receive cyclosporine treatment or encounter blood pressure elevation (before transplant) also develop hypertension in many clinical scenarios[11].

    LIVER TRANSPLANTATION

    Liver transplantation is the gold standard in a patient with end-stage liver disease. Immunosuppressive therapy is required to reduce rejection after transplantation[12]. Unfortunately, more than half of the liver transplant patients develop hypertension that impacts their prognosis and treatment outcomes six months after surgery. In addition, post-transplant hypertension develops among liver transplant patients based on their calcineurin inhibitor/steroid use, family history of hypertension, obesity, and older age. However, the tacrolimus use, and race of liver transplantation patients do not increase their risk for episodic hypertension[13].

    BONE MARROW TRANSPLANTATION

    Approximately 2.4% of bone marrow transplant recipients develop pulmonary hypertension that potentially deteriorates their quality of life, life expectancy, and quality-adjusted life-years[14]. The progressive elevation in pulmonary vascular resistance often triggers right ventricular dysfunction and mortality among bone marrow transplant patients. Hemopoietic cell transplantation among adults and children predisposes them to systemic hypertension during the initial two years of their recovery. Sixtyone percent of adults/children experience new-onset hypertension within one month of their hemopoietic cell transplant[15,16].

    Etiology

    The surgical interventions, immunosuppressive therapy/immune system deterioration, and recipient/donor factors potentially impact the hypertension etiology in patients with organ transplant status.

    Donor factors

    Hypertension among organ transplant patients also develops under the impact of deceased donor renal graft[17]. Medical literature provides inclusive findings concerning the impact of donor hypertension on the hypertension predisposition of organ transplant patients; however, it independently increases the risk for renal allograft failure[18]. The donor's age often determines the post-transplant hypertension risk of the organ transplant candidates[19]. The kidney transplant patients whose donors exhibit a history of familial hypertension experience ten times greater risk of blood pressure elevation than the patients whose donors do not report a family history of hypertension[12]. The differences between the donors' age and body surface area and their organ recipients also predispose them to episodic hypertension. The nephron underdosing due to reduced recipient/donor body weight ratio potentially triggers chronic inflammation among organ transplant patients, which eventually predisposes them to diabetes mellitus, post-transplant hypertension, and chronic rejection of transplanted organs[20].

    Recipient factors

    The clinical studies provide inconclusive evidence concerning the impact of behavioral patterns of organ transplant patients on their hypertension predisposition. However, alcohol consumption, smoking, salt intake, and obesity deteriorate the clinical outcomes of organ transplant patients and increase their risk of hypertension compared to the general population. The organ transplant candidates with pretransplant hypertension and obesity experience a high risk of posttransplant hypertension[17-22]. Stable kidney transplant patients with hypovolemia experience a high risk of elevated mean arterial/ diastolic/systolic blood pressures[23]. Post-transplant hypertension also develops under the impact of comorbidities (including endocrine tumors and obstructive sleep apnea) and the age of the recipients.

    Transplant renal artery stenosis

    The development of transplant renal artery stenosis (TRAS) under the impact of renal artery stenosis reduces the vascular supply to the allograft. TRAS triggers hypertension among 1%-5% of renal transplant recipients[24,25]. The initial six months to two years after organ transplant predispose the treated patients to TRAS-related complications[26]. TRAS manifests with transplant dysfunction, water/salt retention, renal function deterioration, and refractory hypertension. The organ transplant patients eventually experience acute pulmonary edema and hypertensive crisis[26]. TRAS-induced hypoperfusion triggers renin-angiotensin-aldosterone system (RAAS) that potentiates renovascular hypertension in patients with organ transplant status[26]. The potential causes of transplant renal artery stenosis include immune-mediated endothelial deterioration, recipient/donor artery trauma, suturing techniques, donor artery atheroma, and renal artery lesions[27]. TRAS assessment relies on conventional angiography; however, TRAS correction and enhancement of blood pressure/renal perfusion warrants renal vascularizationviaPCTA (percutaneous transluminal coronary angioplasty)[26].

    Acute rejection and chronic allograft injury

    Hypertensive crisis in organ transplant patients correlates with acute and chronic allograft injury. However, clinical studies provide inconclusive evidence concerning a causal relationship between hypertension and allograft deterioration[22].

    Acute rejection

    The cases of acute organ rejection warrant diagnostic assessment concerning post-transplant hypertension. The therapeutic management of acute organ rejection often corrects the systolic and diastolic blood pressure elevations in organ transplant patients. These outcomes substantiate the acute organ rejection attribution of hypertension in organ transplant scenarios[22].

    Chronic graft injury

    The chronic renal allograft injury emanates from recurrent glomerular disease, thrombotic microangiography, tubular atrophy, interstitial fibrosis, and chronic antibody-mediated organ rejection. The focal segmental glomerulosclerosis predominantly associates with hypertension in patients with organ transplant status. The current body of evidence provides inconclusive evidence concerning the causeand-effect relationship between renal allograft dysfunction and hypertensive crisis among organ transplant patients. However, the findings from a preclinical study advocate the potential of hypertension to cause allograft deterioration in organ transplant scenarios[28].

    Immunosuppressive drugs

    The toxic effects of immunosuppressive drugs often elevate the risk of hypertension among organ transplant patients.

    Steroids

    The organ rejection prevention protocol concerning transplantation scenarios relies on the systematic administration of methylprednisolone and prednisone. Corticosteroid maintenance therapy potentially triggers a range of morbidities and comorbidities among patients with organ transplant status. It also increases their risk of hypertension to multiple folds. A plausible mechanism concerning steroidinduced hypertension attributes to volume expansion/sodium retention due to mineralocorticoid receptor overstimulation in organ transplant patients. The exclusion of steroids from the immunosuppressive therapy to mitigate the risk of hypertension could, however, trigger organ rejection and its fatal complications. A recently reported meta-analysis confirmed a 48% incidence of acute organ rejection in patients who did not receive steroids with their immunosuppressive therapies compared to 30% organ rejection incidence among patients who received steroid-controlled immunosuppressive treatments[29].

    Calcineurin inhibitors

    The multifactorial characteristics of calcineurin inhibitor-induced hypertension are widely debated in the medical literature. The calcineurin inhibitors impact the function of the sodium-potassium pump/sympathetic nervous system and vascular tone that eventually triggers a hypertensive crisis in patients with organ transplants. They further induce nitric oxide metabolism by triggering nicotinamide adenine dinucleotide phosphate oxidase-induced angiotensin-II release in the context of intrarenal renin-angiotensin system activation[30]. Furthermore, renal/systemic vasoconstriction often develops under the impact of cyclosporine therapy[31]. The endothelial receptor type A across preglomerular arteries triggers endothelin production that eventually leads to renal vasoconstriction in organ transplant recipients[29,32]. The clinical studies demonstrated cardioprotective effects of tacrolimus compared to cyclosporin in the setting of organ transplantation[33]. They also reveal the superiority of tacrolimus over cyclosporin in controlling blood pressure elevations among organ transplant patients[21]. Research evidence confirms blood pressure elevation in organ transplant recipients on cyclosporin treatment after increasing their dietary sodium intake. This increase in blood pressure indicates the incidence of sodium-dependent hypertension among patients after their organ transplantation[34]. However, the clinical studies do not provide conclusive evidence related to the sodium retaining effects of calcineurin inhibitors in organ transplant scenarios[35]. However, the medical literature indicates the potential of cyclosporin inhibitors in elevating the activity of sodium-potassium chloride/sodium chloride cotransporters for maximizing sodium reabsorption in organ transplant patients[36]. The clinical studies also emphasize the possibility of replacing calcineurin inhibitors with sirolimus based on its safety profile and least impact on the 24 h systolic blood pressures of patients with organ transplant status.

    PREVENTION MEASURES

    Organ transplant-related hypertension prevention warrants the mitigation of risk factors that potentially aggravate systolic and diastolic blood pressures in the treated patients. These risk factors include native kidneys, donor hypertension, smoking, drug use, obstructive sleep apnea, and obesity[37,38]. The findings from various clinical studies recommend lifestyle/behavioral modifications and weight reduction strategies for organ transplant recipients to minimize their risk of postprocedural hypertension. They also advocate the need for evaluating suprarenal masses based on their hypertension attribution[39].

    The long-term use of calcineurin inhibitors, including tacrolimus and cyclosporine among organ transplant patients, clinically correlates with their hypertensive crises. The clinical studies reveal a reduced impact of tacrolimus (compared to cyclosporine) on the blood pressure levels of organ transplant patients[40]. The organ transplant recipients who receive tacrolimus also exhibit a limited dependence on antihypertensive drugs for managing their blood pressure levels[37]. The clinicians accordingly recommend tacrolimus over cyclosporine for the medical management of organ transplant patients. The medical literature alternatively recommends the selective T-cell co-stimulation blocker (Belatacept) to control T cell proliferation and cytokine production in renal transplant patients for effectively managing their episodic hypertension[41].

    The clinical studies further advocate the deleterious impact of corticosteroids on the blood pressure management of organ transplant patients. They provide substantial evidence concerning the dosedependent relationship between corticosteroid utilization and hypertensive crisis in organ transplant scenarios. The clinicians accordingly recommend minimal dosages of steroids (for example, 5 mg per day dose of prednisone) to achieve long-term immunosuppression in organ transplant patients without increasing their risk for episodic hypertension[42].

    The worsening of hypertension in kidney transplant patients clinically correlates with their antibodymediated and acute cellular organ rejection[43]. The subsequent administration of immunosuppressive therapy (based on thyroglobulin, immunoglobulins, and steroids for reversing organ rejection) further exacerbates the hypertensive crisis[44]. These findings necessitate the development of comprehensive treatment protocols to minimize hypertensive crisis without compromising the outcomes of immunosuppressive therapies in organ transplantation scenarios.

    The clinical studies reveal the impact of expanded criteria donor recipient status on worsening cardiovascular complications and hypertensive crises in patients with organ transplant status[45]. Organ transplant patients prevalently develop diabetes, chronic rejection, and hypertension under the impact of reduced donor/recipient body weight ratio[20]. Posttransplant hypertension also triggers under the impact of aortorenal donor atheroma in various clinical scenarios[19]. The medical literature accordingly recommends selecting young and normal-weight donors without a confirmed diagnosis of hypertension or atherosclerosis to minimize the risk of hypertension among organ transplant patients.

    A range of genetic factors contributes to the development of hypertensive crises in organ transplant patients. The presence of apolipoprotein L-1 variants in deceased African American donors potentiates early graft dysfunction and eventual blood pressure elevation in the recipients of transplanted organs. The polymorphisms in CYP3A5, ABCC2, and ABC1 transporters further attribute to posttransplant hypertension and poor graft survival in organ transplant scenarios[46,47]. The assessment of these genetic mechanisms and factors is paramount to minimizing the risk of posttransplant hypertension among organ transplant patients.

    Post-transplant hypertension also develops under the impact of transplanted renal artery stenosis following kidney transplantation[48]. The clinical studies reveal substantial improvements in blood pressure levels of organ transplant patients after the medical management of their renal artery stenosis[49]. These findings substantiate early diagnosis and therapeutic management of renal artery stenosis to reduce the incidence of posttransplant hypertension and its critical complications.

    The therapeutic management of posttransplant hypertension relies on the systematic administration of calcium channel blockers, beta-blockers, and loop diuretics (for volume optimization). The normalization of serum potassium levels and enhancement of kidney function of organ transplant patients further depends on angiotensin receptor blockers and angiotensin-converting enzyme inhibitors[38].

    The hypertension risk factors among liver transplant recipients include new-onset hepatic steatosis, alcoholic cirrhosis, and rapamycin use[50]. These findings advocate the need for monitoring organ transplant patients on mTOR inhibitor therapies to reduce their incidence of hypertensive crises.

    The patients with allogenic hematopoietic stem cell/bone marrow transplant experience a high risk of hypertension based on several factors including graftvshost disease, mycophenolate/calcineurin inhibitor therapies, and lymphoma/Leukemia history[51]. Other hypertension predisposing factors concerning stem cell transplant scenarios include serum creatinine elevation, sinusoidal obstruction syndrome, amphotericin-B therapy, and the young age of the patients in pediatric hematopoietic stem cell transplant[15]. The clinical studies accordingly advocate consistent monitoring of the bone marrow transplant patients based on their dependence on amphotericin-B, mycophenolate, and calcineurin inhibitors.

    DIAGNOSTIC PARAMETERS

    The diagnostic assessment of hypertension in organ transplant scenarios relies on 24 h ambulatory/ home/office blood pressure monitoring interventions. The office blood pressure assessment warrants the recording of three consecutive blood pressure readings and calculation of their mean value. The home blood pressure monitoring requires averaging two blood pressure readings obtained at home within a tenure of 4 days. The 24 h ambulatory blood pressure assessment relies on averaging various blood pressure readings obtained within a day's durationviaa digital blood pressure monitor[1]. The 24 h blood pressure evaluation also helps categorize systolic/diastolic blood pressure levels based on their reverse dipping, dipping, and non-dipping patterns.

    The clinical studies emphasize marked differences between clinical blood pressure monitoring, home blood pressure assessment, and ambulatory blood pressure monitoring. These studies also advocate the requirement of practicing care and caution while measuring the blood pressure levels of organ transplant patients. The clinical findings prioritize the use of ambulatory blood pressure monitoring for investigating the occurrence of whitecoat/masked/nocturnal hypertension to rule out the risk of cardiovascular complications[52].

    The medical literature reveals a substantial increase in night-time systolic blood pressure following kidney transplantation[53]. The 24 h ambulatory blood pressure monitoring effectively tracks nocturnal blood pressure variations in organ transplant patients[54]. This blood pressure evaluation approach is the method of choice for tracking posttransplant hypertension and is recommended over home/office blood pressure monitoring interventions[55].

    The diagnostic affirmation of posttransplant hypertension thoroughly relies on the appropriate use of blood pressure recording interventions. The blood pressure monitored at the physician's office may not give an accurate outcome based on the risk of masked/whitecoat hypertension and circadian variation/diurnal rhythm. Masked hypertension could increase the risk of native kidney disease among renal transplant patients[56]. However, clinical studies do not provide conclusive findings determining the impact of masked hypertension on the outcomes of renal transplant patients. These diagnostic intricacies warrant the use of automated electronic devices for blood pressure monitoring to minimize the risk of masked hypertension and the whitecoat effect in organ transplant scenarios[57].

    The medical literature advocates optimizing blood pressure cutoff limits to accurately identify the existence or absence of hypertension and initiate antihypertensive therapies for organ transplant patients. The diagnostic parameters for assessing hypertension in posttransplant scenarios rely on the following parameters[4]: Office blood pressure reading of greater than 140/90 mmHg.

    An ambulatory blood pressure reading of greater than 135/85 mmHg (awake state) and 120/70 mmHg (sleeping state) The recommendations by KDIGO (Kidney Disease Improving Global Outcomes) advocate the need to administer antihypertensive therapies to kidney transplant patients following their blood pressure elevation above 130/80 mmHg[58].

    MAJOR COMPLICATIONS

    Approximately 50%-80% of adult organ transplant recipients develop hypertension and its clinical complications. The past medical history of hypertension further increases the incidence of posttransplant hypertension. Additionally, the old age of donors, elevated body mass index, male gender, and African American race include the significant demographic factors attributing to the development of hypertension among organ transplant patients[43].

    Types of complications

    Medical literature reports a 50% prevalence of hypertensive among patients with organ transplant status[43]. Posttransplant hypertension predominantly triggers graft dysfunction and cardiovascular events in organ transplant patients that eventually lead to their renal failure. The cardiovascular complications related to posttransplant hypertension include coronary artery disease and congestive heart failure. Uncontrolled hypertension in the setting of kidney transplants potentially disrupts cardiorenal outcomes by impacting the overall functions of the heart and renal allograft[21,59].

    Cardiovascular complications due to post-transplant hypertension

    The recipients of kidney transplants experience a 3%-5% incidence of non-fatal/fatal cardiovascular episodes. They further experience a 50-fold predisposition to cardiorenal complications compared to the general population[60]. Posttransplant mortality often attributes to critical cardiovascular complications emanating from hypertensive crises. The cardiovascular compromise develops under the impact of posttransplant hypertension and elevates the incidence of morbidity/mortality among the treated patients. The cardiovascular episodes attribute to forty percent of patient deaths in the setting of a kidney transplant[4]. The predominant cardiovascular complications emanating from posttransplant hypertension include stroke, arterial narrowing, coronary artery disease, congestive heart failure, and ischemic heart disease. The kidney transplant scenarios also report a high incidence of diastolic dysfunction, left atrial enlargement and left ventricular hypertrophy. Heart failure with decreased left ventricular ejection fraction potentially increases the mortality risk among organ transplant patients. The clinical studies reveal a strong association between nocturnal hypertension and left ventricular hypertrophy in various organ transplant scenarios[4].

    Graft dysfunction due to post-transplant hypertension

    The graft dysfunction in posttransplant scenarios predominantly develops under the impact of hypertensive crisis. The deterioration in renal function also correlates with blood pressure elevation in the setting of organ transplants. The renal allograft injury triggered by posttransplant hypertensioninduced kidney failure further aggravates episodic hypertension and its potential manifestations[43]. The clinical studies continue to examine the relationship between independent allograft survival and blood pressure levels of organ transplant patients.

    The retrospective study by Opelzet al[61] (1998) based on 29571 renal transplant recipients revealed the adverse impact of posttransplant hypertension on the renal allograft injury patterns[61]. Another clinical study indicated improvements in cardiovascular mortality and renal allograft function after therapeutic management of systolic blood pressure of patients within 1-3 years of their kidney transplantation[22]. The study outlined positive clinical outcomes in organ transplant recipients with a marked reduction in systolic blood pressure (below 140 mmHg).

    A clinical study revealed improvements in renal transplant survival rates among patients with reduced diastolic pressures (ranging between 89-99 mmHg). The study findings advocated the need for monitoring mean arterial/diastolic/systolic blood pressures of the renal transplant patients until one year after transplantation to enhance their allograft survival. The study outcomes further correlated the risk of allograft failure for every 10 mmHg diastolic/systolic blood pressure elevation[61]. The clinical studies also indicate blood pressure reduction is a protective factor for kidney transplant recipients during the initial year of their recovery[4,22]. The evidence-based findings clinically correlate graft failure/chronic allograft nephropathy, renal failure, and cardiovascular compromise with posttransplant hypertension. Organ transplant patients with hypertension accordingly experience a high risk of morbidity and mortality[61].

    MEDICAL MANAGEMENT

    The treatment guidelines for managing posttransplant hypertension do not differ from the therapeutic protocols adopted for treating hypertension/blood pressure elevation among patients with a high risk for cardiovascular complications (Table 12-3). The clinical studies reveal the impact of diabetes/proteinuria and cardiovascular conditions on the blood pressure elevation in organ transplant patients. The maintenance of systolic/diastolic blood pressure below 140/90 mmHg is highly necessary to reduce the risk of posttransplant hypertensive crisis. The multifactorial origin of posttransplant arterial hypertension in renal transplant cases warrants its systematic monitoring and medical management. Posttransplant hypertension/hypertensive crisis further intensifies under the impact of allograft nephropathy and immunosuppressive therapies. The diagnostic interventions to track and evaluate the causative factors of posttransplant hypertension include assessing 24 h urinary sodium, proteinuria, 24 h urine clearance, renal function tests, and hepatic panel. The candidates for kidney transplantation qualify for renal ultrasound in the context of evaluating their urinary tract blockage and renal artery stenosis.

    Table 1 Management for hypertension following renal transplantation

    Table 2 Target Blood pressure guideline for kidney transplant recipients

    Table 3 Studies regarding the management of posttransplant hypertension

    The pretransplant hypertension of kidney transplant recipients warrant antihypertensive therapy. The clinical studies reveal rare cases (concerning kidney transplantation) that achieve normotensive status in the absence of antihypertensive therapy. These outcomes necessitate pharmacological management of hypertension of kidney transplant patients to reduce the risk of their cardiovascular complications[22]. The non-pharmacological approaches for hypertension management in kidney transplant scenarios rely on lifestyle modification, stress reduction, weight management, smoking cessation, low-salt diet, and exercise management. Clinical studies need to explore the complex interplay between pharmacodynamics and pharmacokinetics of antihypertensive medications to optimize their use in organ transplant scenarios. They also need to investigate drug-drug interactions and their impact on comorbidities and hypertension management of organ transplant patients[62].

    The renal transplant scenarios report a high incidence of hypertension emanating from corticosteroid therapy. The novel organ transplantation protocols advocate the exclusion of corticosteroid treatment to minimize the risk of hypertensive crises or episodic hypertension[22]. However, the clinical studies provide inconclusive evidence concerning the discontinuation timings of steroid therapies for renal transplant patients. The researchers continue to debate regarding the early or late withdrawal of steroid treatments in organ transplant scenarios. Few clinical studies alternatively negate the contention related to the impact of steroid therapies on the hypertensive crisis of organ transplant patients[37].

    The medical literature provides some evidence concerning the need for manipulating the currently deployed immunosuppressive therapies to optimize the hypertension management of patients with organ transplant status. This belief reciprocates with the adverse impact of immunosuppressive treatments on posttransplant hypertension. Clinical studies showed that cyclosporine increases the risk of posttransplant hypertension compared to tacrolimus[63]. Furthermore, clinical studies also confirm a marked reduction in systolic/diastolic blood pressures following the dose reduction of cyclosporine or its replacement with tacrolimus in organ transplant scenarios[41]. These findings warrant investigation concerning the hypertension induction effect of cyclosporine in organ transplant patients. The impact of cyclosporine on renal sodium retention probably triggers vasoconstriction of glomerular arterioles leading to posttransplant hypertension[43].

    Posttransplant hypertension management primarily relies on first-line therapies based on dihydropyridine calcium channel blockers since they effectively minimize calcineurin-induced vasoconstriction. The beta-blocker therapies further improve the survival rate of organ transplant recipients irrespective of their predisposition to cardiovascular complications[64]. The antihypertensive therapies in organ transplant scenarios must exclude ACE (angiotensin-converting enzyme) inhibitors during the initial 3-6 mo based on the risk of hyperkalemia, anemia, and reduction in glomerular filtration rate[2].

    The medical literature provides evidence concerning the development of posttransplant hypertension despite administering antihypertensive therapies. The evidence-based findings elaborate on the necessity for renal arteriography to rule out renal artery stenosis in organ transplant patients. The patients who develop more than 80% renal arterial stenosis qualify for percutaneous transluminal angioplasty. Renal denervation is another viable therapy with the potential to manage refractory hypertension in organ transplant scenarios[4].

    CONCLUSION

    Posttransplant hypertension increases the risk of graft-related complications in patients with a known history of (pretransplant) hypertension. Steroids, cyclosporine, calcineurin inhibitors, and other immunosuppressive drugs further increase the predisposition of organ transplant patients to hypertension. Hemopoietic cell transplantation predominantly adds to the 2-year risk of systemic hypertension in children and adults. The donor factors for episodic hypertension attributes to the donors' age and body surface area. The recipient factors, however, include hypovolemia and preexisting comorbidities. TRAS-induced hypoperfusion triggers RAAS that potentiates renovascular hypertension in organ transplant patients. Posttransplant hypertension is a significant cause of cardiovascular complications and graft dysfunction. The 24 h blood pressure monitoring is, therefore, necessary to effectively manage hypertensive crises in organ transplant recipients. The evaluation also helps categorize systolic/diastolic blood pressure levels based on their reverse dipping, dipping, and non-dipping patterns.

    FOOTNOTES

    Author contributions:All authors contributed equally in writing, editing, and reviewing the manuscript of the article.

    Conflict-of-interest statement:The authors declare that there is no conflict of interest.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin:United States

    ORCID number:Mahmoud Nassar 0000-0002-5401-9562; Nso Nso 0000-0002-0340-169X; Sofia Lakhdar 0000-0001-5320-2990; Ravali Kondaveeti 0000-0003-2335-5296; Chandan Buttar 0000-0003-4777-5439; Harangad Bhangoo 0000-0001-8893-3005; Mahmoud Awad 0000-0002-9243-3449; Naveen Siddique Sheikh 0000-0002-8549-2029; Karim M Soliman 0000-0002-0960-2644; Most Sirajum Munira 0000-0002-4691-1550; Farshid Radparvar 0000-0001-9631-9208; Vincent Rizzo 0000-0002-5530-447X; Ahmed Daoud 0000-0001-6311-3887.

    S-Editor:Wu YXJ

    L-Editor:A

    P-Editor:Wu YXJ

    黑人猛操日本美女一级片| 亚洲激情五月婷婷啪啪| 亚洲av成人精品一区久久| 王馨瑶露胸无遮挡在线观看| 丰满乱子伦码专区| 精品一区在线观看国产| 大码成人一级视频| 色哟哟·www| 美女cb高潮喷水在线观看| 亚洲人成网站在线播| 久久久久久久久久成人| 亚洲精品亚洲一区二区| 一级毛片电影观看| 亚洲国产精品成人久久小说| 久久这里有精品视频免费| 久久人妻熟女aⅴ| 亚洲怡红院男人天堂| 色哟哟·www| 精品一区二区三区视频在线| 成人午夜精彩视频在线观看| 亚洲av中文av极速乱| 国产亚洲欧美精品永久| 午夜福利影视在线免费观看| 少妇精品久久久久久久| 午夜福利在线观看免费完整高清在| www.色视频.com| 国产免费视频播放在线视频| 国产精品久久久久久久久免| 看免费成人av毛片| 日韩制服骚丝袜av| 国产精品久久久久成人av| 久久精品国产鲁丝片午夜精品| 精品一品国产午夜福利视频| 人人妻人人澡人人爽人人夜夜| 在线观看av片永久免费下载| 看非洲黑人一级黄片| 五月玫瑰六月丁香| 精品人妻熟女av久视频| 91精品一卡2卡3卡4卡| 久久免费观看电影| 成人18禁高潮啪啪吃奶动态图 | 多毛熟女@视频| 高清欧美精品videossex| 国产乱人偷精品视频| 久久久国产精品麻豆| 久久精品国产自在天天线| 亚洲精品久久午夜乱码| 自线自在国产av| 看免费成人av毛片| 成人国产av品久久久| 在现免费观看毛片| 99久久精品一区二区三区| 亚洲国产精品一区二区三区在线| 精品久久国产蜜桃| 水蜜桃什么品种好| 日日摸夜夜添夜夜添av毛片| 又大又黄又爽视频免费| 午夜福利影视在线免费观看| 国产一区有黄有色的免费视频| 大陆偷拍与自拍| 亚洲av.av天堂| av国产久精品久网站免费入址| 高清毛片免费看| 夫妻性生交免费视频一级片| 日韩制服骚丝袜av| 精品一区二区三区视频在线| 麻豆成人av视频| 在线观看免费日韩欧美大片 | 少妇人妻 视频| 一级片'在线观看视频| 精品一区在线观看国产| 9色porny在线观看| 黑人猛操日本美女一级片| 日本爱情动作片www.在线观看| 春色校园在线视频观看| 久久精品久久久久久久性| 丝袜喷水一区| 亚洲欧美一区二区三区黑人 | 伊人久久精品亚洲午夜| 亚洲天堂av无毛| av国产精品久久久久影院| 久热久热在线精品观看| 成人免费观看视频高清| 国产一区亚洲一区在线观看| 亚洲欧美日韩另类电影网站| 国产在线视频一区二区| 最近最新中文字幕免费大全7| 亚洲欧美清纯卡通| 又黄又爽又刺激的免费视频.| 成年美女黄网站色视频大全免费 | 丝袜脚勾引网站| 成人午夜精彩视频在线观看| 少妇被粗大猛烈的视频| 亚洲婷婷狠狠爱综合网| 一级毛片aaaaaa免费看小| 日韩一本色道免费dvd| 男女国产视频网站| 欧美日韩亚洲高清精品| 在线天堂最新版资源| 亚洲av成人精品一二三区| 国产成人a∨麻豆精品| 日日啪夜夜爽| av网站免费在线观看视频| a级毛片免费高清观看在线播放| 三级国产精品片| 伊人久久精品亚洲午夜| 日韩中文字幕视频在线看片| 免费黄色在线免费观看| 亚洲国产精品999| 哪个播放器可以免费观看大片| 久久6这里有精品| 高清毛片免费看| 精品国产露脸久久av麻豆| xxx大片免费视频| 欧美日韩av久久| 97超碰精品成人国产| av播播在线观看一区| 日本爱情动作片www.在线观看| 欧美成人午夜免费资源| 另类亚洲欧美激情| 日本免费在线观看一区| 国产精品一区二区三区四区免费观看| 波野结衣二区三区在线| 亚洲av中文av极速乱| 看非洲黑人一级黄片| 男女国产视频网站| 国产在视频线精品| 精品99又大又爽又粗少妇毛片| 老司机影院毛片| 97超视频在线观看视频| 色视频www国产| 九草在线视频观看| 桃花免费在线播放| 国产亚洲一区二区精品| 你懂的网址亚洲精品在线观看| 午夜激情久久久久久久| 欧美日韩亚洲高清精品| 成年美女黄网站色视频大全免费 | 99久国产av精品国产电影| 日韩一区二区视频免费看| 亚洲精品久久久久久婷婷小说| 久久97久久精品| 伊人久久国产一区二区| 男女免费视频国产| 成人特级av手机在线观看| 国产精品久久久久久精品古装| 少妇高潮的动态图| 欧美另类一区| 久久精品国产鲁丝片午夜精品| 午夜福利网站1000一区二区三区| 青青草视频在线视频观看| 免费黄网站久久成人精品| 全区人妻精品视频| 少妇裸体淫交视频免费看高清| 免费黄网站久久成人精品| 日本黄大片高清| 中国国产av一级| 在线亚洲精品国产二区图片欧美 | 欧美精品国产亚洲| 香蕉精品网在线| 大陆偷拍与自拍| 有码 亚洲区| 一级av片app| 老司机影院毛片| 色哟哟·www| 国产成人aa在线观看| 免费看日本二区| 嫩草影院新地址| 亚洲婷婷狠狠爱综合网| 国产精品伦人一区二区| 久久精品熟女亚洲av麻豆精品| 亚洲av二区三区四区| 日本av免费视频播放| av免费在线看不卡| 欧美日韩视频高清一区二区三区二| 一本一本综合久久| 国产91av在线免费观看| 尾随美女入室| 国内少妇人妻偷人精品xxx网站| 九九久久精品国产亚洲av麻豆| 青春草亚洲视频在线观看| 老司机亚洲免费影院| 亚洲美女搞黄在线观看| a级片在线免费高清观看视频| 永久网站在线| 免费不卡的大黄色大毛片视频在线观看| 性色avwww在线观看| 免费黄网站久久成人精品| 黄色日韩在线| 久久久久人妻精品一区果冻| 欧美丝袜亚洲另类| 麻豆成人av视频| 成人亚洲欧美一区二区av| 日韩欧美一区视频在线观看 | 中国三级夫妇交换| 午夜激情久久久久久久| 国产精品久久久久成人av| 人妻 亚洲 视频| 久久久亚洲精品成人影院| 国国产精品蜜臀av免费| 少妇熟女欧美另类| 麻豆成人av视频| 免费播放大片免费观看视频在线观看| 午夜福利视频精品| 在线观看人妻少妇| 午夜福利在线观看免费完整高清在| 国国产精品蜜臀av免费| 三级国产精品片| 高清视频免费观看一区二区| 男的添女的下面高潮视频| 九色成人免费人妻av| 老司机影院成人| 国产日韩欧美亚洲二区| 永久网站在线| 黑人高潮一二区| 亚洲国产色片| 大又大粗又爽又黄少妇毛片口| 久久久午夜欧美精品| 人人妻人人添人人爽欧美一区卜| 嘟嘟电影网在线观看| 国产成人精品福利久久| 日韩不卡一区二区三区视频在线| 热re99久久国产66热| 老女人水多毛片| 天天操日日干夜夜撸| 国产成人精品婷婷| 丝袜脚勾引网站| av视频免费观看在线观看| 91午夜精品亚洲一区二区三区| 国产精品三级大全| 曰老女人黄片| 搡老乐熟女国产| 午夜激情福利司机影院| 国产在线男女| 这个男人来自地球电影免费观看 | 国产成人精品久久久久久| 一区二区av电影网| 免费观看的影片在线观看| 精品人妻一区二区三区麻豆| 成人亚洲欧美一区二区av| 大码成人一级视频| 黄色视频在线播放观看不卡| 人人妻人人看人人澡| 亚洲国产av新网站| 日日爽夜夜爽网站| 狠狠精品人妻久久久久久综合| 女人久久www免费人成看片| 免费播放大片免费观看视频在线观看| 一区二区av电影网| 欧美区成人在线视频| 少妇人妻 视频| 最后的刺客免费高清国语| 国产中年淑女户外野战色| 亚洲,一卡二卡三卡| 最近2019中文字幕mv第一页| 国产一区有黄有色的免费视频| 看十八女毛片水多多多| 日本wwww免费看| av不卡在线播放| 日本91视频免费播放| 国产精品久久久久久久电影| 欧美精品国产亚洲| 午夜激情福利司机影院| 黄色一级大片看看| 久久国产乱子免费精品| 欧美日韩视频高清一区二区三区二| 午夜精品国产一区二区电影| 亚洲欧美一区二区三区黑人 | 精品国产国语对白av| 美女中出高潮动态图| 久久人妻熟女aⅴ| 日本av手机在线免费观看| 欧美精品亚洲一区二区| 国产又色又爽无遮挡免| 深夜a级毛片| 黄色怎么调成土黄色| 成年av动漫网址| 永久免费av网站大全| 色哟哟·www| 久久久久久人妻| 成人亚洲精品一区在线观看| 99久久精品热视频| 春色校园在线视频观看| 亚洲人成网站在线播| 寂寞人妻少妇视频99o| 欧美性感艳星| 免费黄网站久久成人精品| 国产av精品麻豆| 一本色道久久久久久精品综合| 亚洲精品第二区| 亚洲国产日韩一区二区| 女人精品久久久久毛片| 高清欧美精品videossex| 国产欧美日韩精品一区二区| 国产午夜精品久久久久久一区二区三区| 精品少妇内射三级| h视频一区二区三区| 国产真实伦视频高清在线观看| 亚洲欧美日韩卡通动漫| 中文字幕制服av| 中文天堂在线官网| 青春草亚洲视频在线观看| 嘟嘟电影网在线观看| 国产精品99久久久久久久久| 亚洲精品色激情综合| 欧美日韩av久久| 蜜桃在线观看..| 欧美日韩精品成人综合77777| 一级毛片我不卡| 久久狼人影院| 少妇人妻一区二区三区视频| av国产精品久久久久影院| 久热久热在线精品观看| 日韩欧美 国产精品| 国产精品三级大全| 乱码一卡2卡4卡精品| 在线天堂最新版资源| 激情五月婷婷亚洲| 特大巨黑吊av在线直播| 久久99一区二区三区| 国产精品女同一区二区软件| 亚洲人成网站在线播| 国产精品一区二区性色av| 高清午夜精品一区二区三区| √禁漫天堂资源中文www| 超碰97精品在线观看| 大香蕉久久网| 视频区图区小说| 欧美 亚洲 国产 日韩一| 97超碰精品成人国产| 亚洲国产精品专区欧美| 免费观看的影片在线观看| 国产毛片在线视频| 色吧在线观看| 国内精品宾馆在线| 内射极品少妇av片p| 久久久国产一区二区| 免费看av在线观看网站| 精品国产露脸久久av麻豆| 天美传媒精品一区二区| 欧美精品高潮呻吟av久久| 久久久久久久久久久久大奶| 亚洲av电影在线观看一区二区三区| 十八禁高潮呻吟视频 | 中文字幕av电影在线播放| 中文字幕亚洲精品专区| 男女免费视频国产| 久久久精品94久久精品| 晚上一个人看的免费电影| 欧美精品人与动牲交sv欧美| 免费观看性生交大片5| 涩涩av久久男人的天堂| av网站免费在线观看视频| 精品少妇内射三级| av专区在线播放| 国产精品无大码| 一本久久精品| 欧美激情国产日韩精品一区| 久久久久视频综合| 色视频www国产| 色视频在线一区二区三区| 久久久久久久久久久丰满| 欧美亚洲 丝袜 人妻 在线| 婷婷色综合www| 人妻制服诱惑在线中文字幕| 五月玫瑰六月丁香| 欧美成人精品欧美一级黄| 一级毛片黄色毛片免费观看视频| 亚洲欧洲精品一区二区精品久久久 | 狂野欧美白嫩少妇大欣赏| 欧美最新免费一区二区三区| 欧美精品国产亚洲| 国产精品久久久久久久久免| 国产熟女欧美一区二区| 9色porny在线观看| av在线老鸭窝| 国产精品福利在线免费观看| av在线播放精品| 亚洲三级黄色毛片| 哪个播放器可以免费观看大片| 女性被躁到高潮视频| 欧美最新免费一区二区三区| 青春草亚洲视频在线观看| 国产乱人偷精品视频| 在线天堂最新版资源| 我要看日韩黄色一级片| 涩涩av久久男人的天堂| av免费观看日本| 丰满饥渴人妻一区二区三| 欧美精品一区二区大全| 18禁在线无遮挡免费观看视频| 久久久精品免费免费高清| 婷婷色综合大香蕉| 人人澡人人妻人| 成人二区视频| av网站免费在线观看视频| 美女xxoo啪啪120秒动态图| 三级国产精品片| 在线看a的网站| 日韩欧美精品免费久久| 国产探花极品一区二区| 极品人妻少妇av视频| 99久久精品国产国产毛片| 久久精品国产亚洲av涩爱| 免费av中文字幕在线| 少妇精品久久久久久久| 午夜av观看不卡| 国产成人aa在线观看| 天堂中文最新版在线下载| 91精品伊人久久大香线蕉| 日韩一区二区视频免费看| 亚洲综合色惰| 丝袜在线中文字幕| 国产黄色免费在线视频| 亚洲欧美清纯卡通| av有码第一页| 偷拍熟女少妇极品色| 亚洲第一av免费看| 亚洲精品,欧美精品| 色婷婷久久久亚洲欧美| 成人免费观看视频高清| 一级二级三级毛片免费看| 国产一区有黄有色的免费视频| 汤姆久久久久久久影院中文字幕| 热re99久久国产66热| 国产成人一区二区在线| 色哟哟·www| 日韩视频在线欧美| 亚洲国产精品专区欧美| 精品少妇内射三级| 日日摸夜夜添夜夜添av毛片| 黑人猛操日本美女一级片| 青春草视频在线免费观看| 精品久久久久久久久亚洲| 亚洲精品成人av观看孕妇| 纵有疾风起免费观看全集完整版| 2021少妇久久久久久久久久久| 看十八女毛片水多多多| 黄色怎么调成土黄色| 久久亚洲国产成人精品v| 精品久久国产蜜桃| 久久国产精品男人的天堂亚洲 | 亚洲欧美成人精品一区二区| 高清av免费在线| 成人美女网站在线观看视频| 女人精品久久久久毛片| 国产深夜福利视频在线观看| 午夜av观看不卡| 韩国高清视频一区二区三区| 91久久精品电影网| 我要看黄色一级片免费的| 亚洲成色77777| 久久韩国三级中文字幕| 国产在线视频一区二区| 青春草亚洲视频在线观看| 久久久欧美国产精品| 欧美另类一区| 日韩欧美一区视频在线观看 | 日日摸夜夜添夜夜添av毛片| 国产精品欧美亚洲77777| 日韩视频在线欧美| 精品午夜福利在线看| 精品一区二区三卡| 97超视频在线观看视频| 日本91视频免费播放| 女人精品久久久久毛片| 国产爽快片一区二区三区| 欧美日韩精品成人综合77777| 青春草国产在线视频| 亚洲欧美精品自产自拍| 精品少妇内射三级| 内射极品少妇av片p| √禁漫天堂资源中文www| 乱人伦中国视频| 91aial.com中文字幕在线观看| 一级黄片播放器| 亚洲av成人精品一二三区| 国产淫片久久久久久久久| 日日摸夜夜添夜夜添av毛片| 国产成人精品无人区| 国产一区二区三区av在线| 男人狂女人下面高潮的视频| 成人黄色视频免费在线看| 中文字幕亚洲精品专区| 又大又黄又爽视频免费| 高清在线视频一区二区三区| 我的女老师完整版在线观看| 久久久国产欧美日韩av| 久久人人爽人人爽人人片va| 国产淫语在线视频| 亚洲怡红院男人天堂| 国产乱人偷精品视频| av免费在线看不卡| 男人狂女人下面高潮的视频| 69精品国产乱码久久久| av线在线观看网站| 少妇被粗大猛烈的视频| 亚洲不卡免费看| 午夜日本视频在线| 一级毛片黄色毛片免费观看视频| 王馨瑶露胸无遮挡在线观看| av福利片在线观看| 91久久精品国产一区二区成人| 成年人免费黄色播放视频 | 一本大道久久a久久精品| 免费av不卡在线播放| 性色avwww在线观看| 欧美日韩一区二区视频在线观看视频在线| 亚洲成人手机| 国产男女超爽视频在线观看| 嫩草影院新地址| 亚洲国产日韩一区二区| 日本av手机在线免费观看| 在线精品无人区一区二区三| 欧美性感艳星| 在线精品无人区一区二区三| 国产黄片视频在线免费观看| 亚洲欧美日韩东京热| 国产成人免费无遮挡视频| 欧美日本中文国产一区发布| 色婷婷久久久亚洲欧美| 国产精品成人在线| 少妇精品久久久久久久| 视频中文字幕在线观看| 日本黄大片高清| 嘟嘟电影网在线观看| 亚洲自偷自拍三级| 亚洲欧美日韩东京热| 色婷婷久久久亚洲欧美| 婷婷色综合大香蕉| 一级毛片aaaaaa免费看小| 高清不卡的av网站| 久久热精品热| 亚洲av在线观看美女高潮| av一本久久久久| av福利片在线观看| a级毛色黄片| 日韩大片免费观看网站| 亚洲久久久国产精品| 国内精品宾馆在线| 69精品国产乱码久久久| 久久婷婷青草| 国产成人免费无遮挡视频| 成人毛片a级毛片在线播放| 如何舔出高潮| 国产男人的电影天堂91| 国产成人精品福利久久| 最近2019中文字幕mv第一页| 免费播放大片免费观看视频在线观看| 80岁老熟妇乱子伦牲交| av国产久精品久网站免费入址| 亚洲精品久久久久久婷婷小说| av在线app专区| 日韩强制内射视频| 日本免费在线观看一区| 丝袜在线中文字幕| 午夜久久久在线观看| 黄色配什么色好看| 欧美精品亚洲一区二区| 色婷婷av一区二区三区视频| 人妻一区二区av| 婷婷色综合www| 日本色播在线视频| 青春草视频在线免费观看| 久久国产亚洲av麻豆专区| 亚洲精品亚洲一区二区| 老女人水多毛片| 久久午夜综合久久蜜桃| 大香蕉久久网| av不卡在线播放| 这个男人来自地球电影免费观看 | 亚洲国产精品999| 国产精品人妻久久久影院| 在线观看人妻少妇| 一级毛片电影观看| 中文字幕制服av| 久久久久视频综合| 在线播放无遮挡| 国产成人免费无遮挡视频| 亚洲国产日韩一区二区| 午夜91福利影院| 欧美日韩综合久久久久久| 老司机影院成人| 国产女主播在线喷水免费视频网站| 99热这里只有是精品在线观看| 欧美日韩视频精品一区| 国产爽快片一区二区三区| 国产精品福利在线免费观看| av黄色大香蕉| 亚洲av福利一区| 人人妻人人爽人人添夜夜欢视频 | 女的被弄到高潮叫床怎么办| 国产成人免费观看mmmm| 国产成人精品一,二区| 美女xxoo啪啪120秒动态图| av视频免费观看在线观看| 中国国产av一级| 性高湖久久久久久久久免费观看| 毛片一级片免费看久久久久| 久久99一区二区三区| 热re99久久精品国产66热6| 亚洲欧洲国产日韩| 国产淫语在线视频| 最近中文字幕高清免费大全6| 亚洲第一区二区三区不卡| 女性被躁到高潮视频| 亚洲精品自拍成人| 狂野欧美白嫩少妇大欣赏| 最黄视频免费看| 大又大粗又爽又黄少妇毛片口| 亚洲精品久久午夜乱码| 全区人妻精品视频| 99热6这里只有精品| 精品国产一区二区久久| 日韩一区二区视频免费看|